Ticker > Company >

Dishman Carbogen Amc share price

Dishman Carbogen Amcis Ltd.

NSE: DCAL BSE: 540701 SECTOR: Pharmaceuticals & Drugs  101k   205   20

242.30
-1.10 (-0.45%)
BSE: 20 Jun 04:01 PM

Price Summary

Today's High

₹ 248.90

Today's Low

₹ 236.60

52 Week High

₹ 307.80

52 Week Low

₹ 155

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

3,798.85 Cr.

Enterprise Value

4,312.93 Cr.

No. of Shares

15.68 Cr.

P/E

0

P/B

0.94

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  257.07

CASH

9.90 Cr.

DEBT

523.98 Cr.

Promoter Holding

59.32 %

EPS (TTM)

₹  -0.63

Sales Growth

-18.68%

ROE

-1.87 %

ROCE

-0.75%

Profit Growth

-29.79 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-18.68%
3 Year17.79%
5 Year-9.84%

Profit Growth

1 Year-29.79%
3 Year18.68%
5 Year-206.41%

ROE%

1 Year-1.87%
3 Year-1.32%
5 Year-1.59%

ROCE %

1 Year-0.75%
3 Year-0.83%
5 Year-0.6%

Debt/Equity

0.13

Price to Cash Flow

157.17

Interest Cover Ratio

-0.51

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 59.32 0.00
Dec 2024 59.32 0.00
Sep 2024 59.32 0.00
Jun 2024 59.32 0.00
Mar 2024 59.32 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 17.79% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 64.00 days.
  • The company has a high promoter holding of 59.32%.

 Limitations

  • Company has a poor ROE of -1.32% over the past 3 years.
  • Company has a poor ROCE of -0.83% over the past 3 years
  • Company has low Interest coverage ratio of -0.51.
  • Company has high debtor days of 184.26.
  • The company has a low EBITDA margin of 3.71% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 42.07.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 111.26 103.41 93.29 97.04 106.10
Total Expenditure 99.69 88.51 79.89 74.08 85.57
Operating Profit 11.57 14.90 13.40 22.96 20.53
Other Income -3.21 11.59 23.93 -8.01 5.47
Interest 15.87 15.73 15.59 17.77 21.31
Depreciation 26.12 16.32 16.30 16.48 16.10
Exceptional Items 0 0 0 0 0
Profit Before Tax -33.63 -5.56 5.44 -19.30 -11.41
Tax -2.51 -2.09 -8.81 -6.02 -4.04
Profit After Tax -31.12 -3.47 14.25 -13.28 -7.37
Adjusted EPS (Rs) -1.98 -0.22 0.91 -0.85 -0.47

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 580.74 200.32 306.61 402.55 327.35
Total Expenditure 407.18 253.11 272.82 394.79 320.55
Operating Profit 173.56 -52.79 33.79 7.76 6.80
Other Income 69.57 66.29 66.11 52.16 63.05
Interest 47.02 34.17 37.23 57.92 68.19
Depreciation 140.65 141.35 140.07 96.20 101.61
Exceptional Items 0 0 -5.91 -2 -3.05
Profit Before Tax 55.46 -162.02 -83.31 -96.20 -103
Tax 16.94 64.12 -52.84 -37.33 -26.59
Net Profit 38.52 -232.81 -31.55 -58.87 -76.41
Adjusted EPS (Rs.) 2.46 -14.42 -1.94 -3.75 -4.87

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 31.38 31.36 31.36 31.36 31.36
Total Reserves 4,764.47 4,643.26 4,200.42 4,082.95 4,021.22
Borrowings 137.90 144.41 134.42 162.57 157.37
Other N/C liabilities 356.70 348.96 444.04 409.68 395.10
Current liabilities 620.44 530.88 551.19 641.60 618.73
Total Liabilities 5,910.89 5,698.87 5,361.43 5,328.16 5,223.78
Assets
Net Block 1,632.53 1,509.65 1,355.98 1,382.30 1,415.63
Capital WIP 57.14 79.36 114.12 141.88 73.35
Intangible WIP 31.71 41.84 3.65 1.01 0.70
Investments 2,843.10 2,814.87 2,811.09 2,837.36 2,834.26
Loans & Advances 576.27 529.74 310.14 315.19 311.95
Other N/C Assets 5.45 0.35 0.66 0.81 0.67
Current Assets 764.69 723.06 765.79 649.61 587.22
Total Assets 5,910.89 5,698.87 5,361.43 5,328.16 5,223.78
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 55.46 -168.69 -84.39 -96.20 -103
Adjustment 135.32 128.11 117.32 100.96 116.86
Changes in Assets & Liabilities 24.14 46.25 200.55 -54.11 11.53
Tax Paid -18.24 -7.18 -6.13 -3.55 -1.22
Operating Cash Flow 196.68 -1.51 227.35 -52.90 24.17
Investing Cash Flow -74.30 62.07 -172.67 40.71 96.57
Financing Cash Flow -124.07 -70.53 -46.16 1.38 -130.76
Net Cash Flow -1.69 -9.97 8.52 -10.81 -10.02

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 59.32 59.32 59.32 59.32 59.32
adimans technologies llp 59.32 59.32 59.32 59.32 59.32
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 40.68 40.68 40.68 40.68 40.68
hbm healthcare investment... 3.55 3.55 3.55 3.55 3.57
investor education and pr... 0.01 - 0.02 0.02 0.02
llp 0.36 0.39 0.30 0.81 0.79
massachusetts institute o... 1.95 1.95 1.95 1.95 2.27
mukul mahavir agrawal 5.74 5.74 5.50 5.50 5.50
investor education and pr... - 0.02 - - -
quant mutual fund - quant... 1.16 - - - -

Annual Reports

Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
Credit FITCH
Credit FITCH
Credit INDIA RATINGS & RESEARCH
Credit FITCH
Credit FITCH
TYPE AGENCY Link
Research HDFC Securities
Research BOB Capital Market
Research Nirmal Bang Institutional
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER Link
Concall Q4FY22
Concall Q3FY24
Concall Q3FY24
Concall Q3FY23
Concall Q1FY25
Concall Q1FY24
Concall Q1FY23
TYPE QUARTER Link
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY22
Presentation Q1FY21

Company News

Dishman Carbogen Amc Stock Price Analysis and Quick Research Report. Is Dishman Carbogen Amc an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Dishman Carbogen Amc and its performance over the period of time. Dishman Carbogen Amc stock price today is Rs 243.80.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Dishman Carbogen Amc cash from the operating activity was Rs 24.17 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Dishman Carbogen Amc has a Debt to Equity ratio of 0.13 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Dishman Carbogen Amc , the EPS growth was -29.79 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Dishman Carbogen Amc has OPM of 2.08 % which is a bad sign for profitability.
     
  • ROE: Dishman Carbogen Amc have a poor ROE of -1.87 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Dishman Carbogen Amc is Rs 243.80. One can use valuation calculators of ticker to know if Dishman Carbogen Amc share price is undervalued or overvalued.
Last Updated on:
Brief about Dishman Carbogen Amc
X